Connect with us

Sport

Former NFL player launches CBD made from orange peel

Peels claims its CBD is unmatched in purity and consistency.

Published

on

Peels CBD
Peels uses a proprietary process of deriving premium-quality CBD from orange peels called Cyclic Terpene Assembly

Former NFL player Chris Hetherington has founded his own CBD – and it’s made from orange peel.

New wellness brand Peels, which officially launched on 3 August, was founded by 11-year NFL veteran and seasoned CEO Chris Hetherington.

Peels’ claims its molecularly identical CBD acts in the body in the same way and has the same holistic benefits as cannabis- and hemp-derived CBD, but without the impurities and variability associated with cannabis and hemp-derived CBD. 

It uses a proprietary process of deriving premium-quality CBD from orange peels, called Cyclic Terpene Assembly, a technique for combining organic molecules without sullying them with solvents or destroying their essence. 

This process combines terpenes from orange peels with olivetol, a naturally occurring organic compound, under heat and pressure in the presence of a catalyst. 

After further processing, the result is crystalline CBD which Peels says is unmatched in purity and consistency.

Making CBD more accessible

The use of CBD in many stressful and physically demanding fields of work, such as professional sports, military, and first responders has previously been prohibited, even if used for medicinal purposes. 

This is due to unregulated amounts of THC found in many cannabis and hemp-derived CBD products that can be detected by periodic drug testing. But with guaranteed zero THC, Peels claims to offer a worry-free CBD experience. 

Former fullback, Hetherington has high expectations for the brand, he commented: “As our CBD is made from orange peels, we have a tremendous opportunity to reach target audiences and potentially enter channels our competitors cannot, thus expanding the existing CBD market and improving the lives of more people. 

“Our priority will always be putting our consumers first by continuously innovating and developing data-driven and science-based products to meet their wellness needs.”

Hetherington continued: “We’re extremely proud of our CBD Oil and we know Peels is going to revolutionise the way people view and use CBD.

“There are so many benefits to this amazing herbal supplement and we’re excited to finally offer 100 percent certified THC-free and Pesticide-free products for those who’ve been reluctant to try CBD in the past.

“With Peels, we’re taking all of the impurities and inconsistencies out of the equation. We believe our CBD products deserve a spot right next to your vitamins as part of your daily wellness ritual.”

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email sarah@handwmedia.co.uk / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2023 PP Intelligence Ltd.